Pulmonx Corp Stock Fundamentals
| LUNG Stock | USD 6.30 0.16 2.48% |
Pulmonx Corp fundamentals help investors to digest information that contributes to Pulmonx Corp's financial success or failures. It also enables traders to predict the movement of Pulmonx Stock. The fundamental analysis module provides a way to measure Pulmonx Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pulmonx Corp stock.
At this time, Pulmonx Corp's Total Revenue is most likely to increase significantly in the upcoming years. The Pulmonx Corp's current Gross Profit is estimated to increase to about 53.3 M, while Net Loss is forecasted to increase to (58.2 M). Pulmonx | Select Account or Indicator |
Pulmonx Corp Company Return On Asset Analysis
Pulmonx Corp's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Pulmonx Corp Return On Asset | -0.2 |
Most of Pulmonx Corp's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pulmonx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Pulmonx Total Assets
Total Assets |
|
Based on the latest financial disclosure, Pulmonx Corp has a Return On Asset of -0.2004. This is 97.71% lower than that of the Health Care Equipment & Supplies sector and 98.89% lower than that of the Health Care industry. The return on asset for all United States stocks is 43.14% higher than that of the company.
Pulmonx Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pulmonx Corp's current stock value. Our valuation model uses many indicators to compare Pulmonx Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pulmonx Corp competition to find correlations between indicators driving Pulmonx Corp's intrinsic value. More Info.Pulmonx Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Pulmonx Corp's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pulmonx Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Pulmonx Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulmonx Corp's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics of similar companies.Pulmonx Corp is currently under evaluation in return on asset category among its peers.
Pulmonx Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pulmonx Corp from analyzing Pulmonx Corp's financial statements. These drivers represent accounts that assess Pulmonx Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pulmonx Corp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 2.5B | 1.2B | 312.7M | 484.2M | 460.0M | |
| Enterprise Value | 1.4B | 2.3B | 1.0B | 235.4M | 442.1M | 420.0M |
Pulmonx Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pulmonx Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pulmonx Corp's managers, analysts, and investors.Environmental | Governance | Social |
Pulmonx Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.69) % | ||||
| Current Valuation | 209.04 M | ||||
| Shares Outstanding | 39.49 M | ||||
| Shares Owned By Insiders | 5.16 % | ||||
| Shares Owned By Institutions | 94.90 % | ||||
| Number Of Shares Shorted | 986.14 K | ||||
| Price To Book | 2.78 X | ||||
| Price To Sales | 3.22 X | ||||
| Revenue | 68.67 M | ||||
| Gross Profit | 39.87 M | ||||
| EBITDA | (55.09 M) | ||||
| Net Income | (60.84 M) | ||||
| Cash And Equivalents | 162.09 M | ||||
| Cash Per Share | 4.35 X | ||||
| Total Debt | 41.42 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.43 X | ||||
| Book Value Per Share | 2.38 X | ||||
| Cash Flow From Operations | (37.61 M) | ||||
| Short Ratio | 4.92 X | ||||
| Earnings Per Share | (1.47) X | ||||
| Price To Earnings To Growth | (0.42) X | ||||
| Target Price | 13.5 | ||||
| Number Of Employees | 279 | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 255.09 M | ||||
| Total Asset | 177.78 M | ||||
| Retained Earnings | (411.16 M) | ||||
| Working Capital | 127.27 M | ||||
| Net Asset | 177.78 M |
About Pulmonx Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 104 K | 102.7 K | |
| Total Revenue | 68.7 M | 72.1 M | |
| Cost Of Revenue | 17.9 M | 18.8 M | |
| Stock Based Compensation To Revenue | 0.32 | 0.34 | |
| Sales General And Administrative To Revenue | 1.31 | 1.00 | |
| Research And Ddevelopement To Revenue | 0.26 | 0.29 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 1.81 | 0.98 | |
| Ebit Per Revenue | (0.90) | (0.95) |
Currently Active Assets on Macroaxis
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:Check out Pulmonx Corp Piotroski F Score and Pulmonx Corp Altman Z Score analysis. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.